Jensen P - Search Results

1

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study.

Leurs CE, Twaalfhoven H, Lissenberg-Witte BI, van Pesch V, Dujmovic I, Drulovic J, Castellazzi M, Bellini T, Pugliatti M, Kuhle J, Villar LM, Alvarez-Cermeño JC, Alvarez-Lafuente R, Hegen H, Deisenhammer F, Walchhofer LM, Thouvenot E, Comabella M, Montalban X, Vécsei L, Rajda C, Galimberti D, Scarpini E, Altintas A, Rejdak K, Frederiksen JL, Pihl-Jensen G, Jensen P, Khalil M, Voortman MM, Fazekas F, Saiz A, La Puma D, Vercammen M, Vanopdenbosch L, Uitdehaag B, Killestein J, Bridel C, Teunissen C. Leurs CE, et al. Among authors: jensen p. Mult Scler. 2020 Jul;26(8):912-923. doi: 10.1177/1352458519845844. Epub 2019 May 8. Mult Scler. 2020. PMID: 31066634 Free PMC article.

2

Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.

Ravnborg M, Bendtzen K, Christensen O, Jensen PE, Hesse D, Tovey MG, Sørensen PS. Ravnborg M, et al. Among authors: jensen pe. Mult Scler. 2009 Mar;15(3):323-8. doi: 10.1177/1352458508099476. Epub 2008 Nov 21. Mult Scler. 2009. PMID: 19028832 Clinical Trial.

3

Soluble serum VCAM-1, whole blood mRNA expression and treatment response in natalizumab-treated multiple sclerosis.

Petersen ER, Søndergaard HB, Oturai AB, Jensen P, Sorensen PS, Sellebjerg F, Börnsen L. Petersen ER, et al. Among authors: jensen p. Mult Scler Relat Disord. 2016 Nov;10:66-72. doi: 10.1016/j.msard.2016.09.001. Epub 2016 Sep 6. Mult Scler Relat Disord. 2016. PMID: 27919501

4

NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis.

Ammitzbøll C, Dyrby TB, Börnsen L, Schreiber K, Ratzer R, Romme Christensen J, Iversen P, Magyari M, Lundell H, Jensen PEH, Sørensen PS, Siebner HR, Sellebjerg F. Ammitzbøll C, et al. Among authors: jensen peh. Mult Scler Relat Disord. 2023 Sep;77:104854. doi: 10.1016/j.msard.2023.104854. Epub 2023 Jun 29. Mult Scler Relat Disord. 2023. PMID: 37418931

5

Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation.

Sellebjerg F, Krakauer M, Hesse D, Ryder LP, Alsing I, Jensen PE, Koch-Henriksen N, Svejgaard A, Soelberg Sørensen P. Sellebjerg F, et al. Among authors: jensen pe. Eur J Neurol. 2009 Dec;16(12):1291-8. doi: 10.1111/j.1468-1331.2009.02716.x. Epub 2009 Jun 22. Eur J Neurol. 2009. PMID: 19558503

6

Efficacy of natalizumab in multiple sclerosis patients with high disease activity: a Danish nationwide study.

Oturai AB, Koch-Henriksen N, Petersen T, Jensen PE, Sellebjerg F, Sorensen PS. Oturai AB, et al. Among authors: jensen pe. Eur J Neurol. 2009 Mar;16(3):420-3. doi: 10.1111/j.1468-1331.2008.02517.x. Eur J Neurol. 2009. PMID: 19364368

7

Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.

Jensen PE, Sellebjerg F, Søndergaard HB, Sørensen PS. Jensen PE, et al. Eur J Neurol. 2012 Oct;19(10):1311-7. doi: 10.1111/j.1468-1331.2012.03721.x. Epub 2012 May 5. Eur J Neurol. 2012. PMID: 22564111

8

Use of azathioprine for non-thymoma myasthenia and risk of cancer: a nationwide case-control study in Denmark.

Pedersen EG, Pottegård A, Hallas J, Friis S, Hansen K, Jensen PE, Gaist D. Pedersen EG, et al. Among authors: jensen pe. Eur J Neurol. 2013 Jun;20(6):942-8. doi: 10.1111/ene.12108. Epub 2013 Feb 28. Eur J Neurol. 2013. PMID: 23448676

9

Myasthenia and risk of cancer: a population-based case-control study.

Pedersen EG, Pottegård A, Hallas J, Friis S, Hansen K, Jensen PE, Gaist D. Pedersen EG, et al. Among authors: jensen pe. Eur J Neurol. 2014 May;21(5):773-8. doi: 10.1111/ene.12383. Epub 2014 Feb 26. Eur J Neurol. 2014. PMID: 24571170

10

Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009.

Pedersen EG, Hallas J, Hansen K, Jensen PE, Gaist D. Pedersen EG, et al. Among authors: jensen pe. Eur J Neurol. 2013 Feb;20(2):309-14. doi: 10.1111/j.1468-1331.2012.03850.x. Epub 2012 Aug 10. Eur J Neurol. 2013. PMID: 22882327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,532 results

Search Page

Filters